ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT06171178 updates: 1. completion date: 2025-09-10 → 2025-09-11 2. primary completion date: 2025-09-10 → 2025-09-11 3. enrollment: not set → 15 participants
Clinical trial NCT06171178 updates: 1. completion date: 2025-09-10 → 2025-09-11 2. primary completion date: 2025-09-10 → 2025-09-11 3. enrollment: not set → 15 participants
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical